← Open Payments lookup

DESIREE MATTHEWS: Open Payments

NPI 1356700561 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$268,698 in 328 payments from 13 companies in 2025. Trend: 2023 $105,492 · 2024 $250,721 · 2025 $268,698

Speaker / faculty: $109,126Consulting: $88,653Travel & lodging: $41,721Honoraria: $22,950Food & beverage: $6,248
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.80$61,785
E.R. Squibb & Sons, L.L.C.52$60,263
Janssen Pharmaceuticals, Inc51$51,221
Teva Pharmaceuticals USA, Inc.39$29,046
Axsome Therapeutics, Inc.25$14,941
Luye Pharma (USA) Ltd.9$11,523
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$9,643
ABBVIE INC.18$9,537
Otsuka Pharmaceutical Development & Commercialization, Inc.11$6,925
Alkermes, Inc.8$5,249

Products named: INGREZZA, INVEGA SUSTENNA, UZEDY, COBENFY, Auvelity, ERZOFRI EXTENDED-RELEASE, CAPLYTA, VRAYLAR.

Industry payments across NC — which companies pay providers there.